Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Penther

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Leukemia|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangementBenoit Ducourneau, Arnaud Pages, Stéphanie Struski, et al.
Blood Advances|October 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2025
Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelinesLoïc Renaud, Marie Donzel, Justine Decroocq, et al.
Blood|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapyNicolas Duployez, Romane Joudinaud, Augustin Boudry, et al.
Blood Advances|April 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA studyVincent Camus, Daphné Krzisch, Alessio Bruscaggin, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Leukemia|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangementBenoit Ducourneau, Arnaud Pages, Stéphanie Struski, et al.
Blood Advances|October 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2025
Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelinesLoïc Renaud, Marie Donzel, Justine Decroocq, et al.
Blood|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapyNicolas Duployez, Romane Joudinaud, Augustin Boudry, et al.
Blood Advances|April 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA studyVincent Camus, Daphné Krzisch, Alessio Bruscaggin, et al.
Pageof 6